Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer

Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer Oncol Ther (2016) 4:103–116 DOI 10.1007/s40487-016-0020-4 ORIGINAL RESEARCH Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer . . . Lourens T. Bloem Richard De Abreu Lourenc ¸o Melvin Chin Brett Ly Marion Haas Received: March 4, 2016 / Published online: May 11, 2016 The Author(s) 2016. This article is published with open access at Springerlink.com in the Sydney metropolitan area, Australia were ABSTRACT identified using the hospital’s database Introduction: To investigate the factors that MOSAIQ . The electronic medical record of affect the choice of 5-fluorouracil (5-FU) or its each patient was manually reviewed to extract oral alternative, capecitabine, as first-line factors potentially affecting treatment choice. treatment in patients with colorectal cancer Logistic regression was used to assess which (CRC). patient and/or treatment factors could explain Methods: Patients treated with 5-FU or the choice between 5-FU or capecitabine. Where capecitabine for CRC between January 1, 2011 it was available in the medical correspondence, and December 31, 2013 in a teaching hospital the explicit reason for the choice made was extracted. Enhanced content To view enhanced content for this Results: 170 CRC patients were included; 119 article go to www.medengine.com/Redeem/ 05C4F060100E857A. on 5-FU, and 51 on capecitabine. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Oncology and Therapy Springer Journals

Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer

Loading next page...
 
/lp/springer-journals/factors-impacting-treatment-choice-in-the-first-line-treatment-of-vjYDbkdwu9
Publisher
Springer Journals
Copyright
Copyright © 2016 by The Author(s)
Subject
Medicine & Public Health; Internal Medicine
ISSN
2366-1070
eISSN
2366-1089
DOI
10.1007/s40487-016-0020-4
Publisher site
See Article on Publisher Site

Abstract

Oncol Ther (2016) 4:103–116 DOI 10.1007/s40487-016-0020-4 ORIGINAL RESEARCH Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer . . . Lourens T. Bloem Richard De Abreu Lourenc ¸o Melvin Chin Brett Ly Marion Haas Received: March 4, 2016 / Published online: May 11, 2016 The Author(s) 2016. This article is published with open access at Springerlink.com in the Sydney metropolitan area, Australia were ABSTRACT identified using the hospital’s database Introduction: To investigate the factors that MOSAIQ . The electronic medical record of affect the choice of 5-fluorouracil (5-FU) or its each patient was manually reviewed to extract oral alternative, capecitabine, as first-line factors potentially affecting treatment choice. treatment in patients with colorectal cancer Logistic regression was used to assess which (CRC). patient and/or treatment factors could explain Methods: Patients treated with 5-FU or the choice between 5-FU or capecitabine. Where capecitabine for CRC between January 1, 2011 it was available in the medical correspondence, and December 31, 2013 in a teaching hospital the explicit reason for the choice made was extracted. Enhanced content To view enhanced content for this Results: 170 CRC patients were included; 119 article go to www.medengine.com/Redeem/ 05C4F060100E857A. on 5-FU, and 51 on capecitabine.

Journal

Oncology and TherapySpringer Journals

Published: May 11, 2016

References